Is neutrophil/lymphocyte and platelet/lymphocyte ratioa predictive factor for the fibrous stage in patients withchronic hepatitis B?

Aim: Neutrophil-lymphocyte ratio (NLR) and platelet-lymphocyte ratio (PLR) are an inexpensive inflammatory marker that can beeasily obtained from the blood count and can be used in many chronic diseases. In our study, we aimed to investigate the relationshipbetween fibrosis stage and NLR, PLR in patients with chronic hepatitis B virus (HBV). Materials and Methods: 173 patients with chronic HBV were included in the study. The demographic data and hemogram parameters ofall patients were recorded. Histopathological data of the patients were documented. Accompanying comorbid diseases, medicationsand previous operations were questioned. In chronic HBV patients, fibrosis level was compared with hematological parameters. Results: A total of 173 patients, 100 (57.8%) of whom were male, were included in the study. As a result of the liver biopsy; mildfibrosis (steage/1-2) in 83(47.9%) patients, moderate fibrosis (steage/3-4) in 35(20.3%) patients and advanced fibrosis (stage/5-6)in 55(31.8%) patients. In advanced fibrosis group, liver function tests and bilirubin levels were significantly higher and albumin levelwas significantly lower (p

PDF

___

1. Lavanchy D. Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures. J Viral Hepat 2004;11:97-107.
2. 2Fattovich G, Bortolotti F, Donato F. Natural history of chronic hepatitis B: special emphasis on disease progression and prognostic factors. J Hepatol 2008;48:335-52
3. Siddique I, El-Naga HA, Madda JP, et al. Sampling variability on percutaneous liver biopsy in patients with chronic hepatitis C virus infection. Scand J Gastroenterol 2003;38:427-32.
4. Hui AY, Chan HL, Wong VW, et al. Identification of chronic hepatitis B patients without significant liver fibrosis by a simple noninvasive predictive model. Am J Gastroenterol 2005;100:616-23.
5. Yilmaz B, Aydin H, Can G, et al. The relationship between fibrosis level and blood neutrophil to lymphocyte ratio in inactive hepatitis B carriers. Eur J Gastroenterol Hepatol 2014;26:1325-2.
6. Kim H, Ro SM, Yang JH, et al.The neutrophiltolymphocyte ratio prechemotherapy and postchemotherapy as a prognostic marker in metastatic gastric cancer Korean J Intern Med 2018;33:990-9.
7. Walsh SR, Cook EJ, Goulder F, et al. Neutrophillymphocyte ratio as a prognostic factor in colorectal cancer. J Sur Oncol. 2005;91:181-4.
8. Alkhouri N, Tamimi TA, Yerian L, et al. The inflamed liver and atherosclerosis: a link between histologic severity of nonalcoholic fatty liver disease and increased cardiovascular risk. Dig Dis Sci 2010;55:2644-50.
9. Kekilli M, Tanoglu A, Sakin YS, et al. Is the neutrophil to lymphocyte ratio associated with liver fibrosis in patients with chronic hepatitis B?. World J Gastroenterol 2015;21:5575.
10. Ates I, Bulut M, Ozkayar N, et al. Association between high platelet indices and proteinuria in patients with hypertension. Ann Lab Med 2015;35:630-4.
11. Coskun BDO, Dizdar OS, Baspınar O, et al. Usefulness of the neutrophil-to-lymphocyte ratio and platelet morphologic parameters in predicting hepatic fibrosis in chronic hepatitis c patients. Ann Clin Lab Sci 2016;46:380-6.
12. Hendra TJ, Oswald GA, Yudkin JS. Increased mean platelet volüme after acute myocardial infarction relates to diabetes and to cardiac failure. Diabetes Res Clin Pract 1988;5:63-9.
13. Rodak AP, Kiciak S, Tomasiewicz K. Neutrophillymphocyte ratio and mean platelet volume as predictive factors for liver fibrosis and steatosis in patients with chronic hepatitis B. Ann Agric Environ Med. 2018;25:690-2.
14. Atay K. Relationship between neutrophil-tolymphocyte ratio, mean platelet volume, and fibrosis level in patients with chronic hepatitis B. The Turkish J Academic Gastroenterology 2019;18:7-11.
15. Knodell RG, Ishak KG, Black WC, et al. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1981;1:431-5.
16. Desmet VJ, Gerber M, Hoofnagle JH, et al. Classification of chronic hepatitis: Diagnosis, grading and staging. Hepatology 1994;19:1513-20.
17. Aygun C, Gozel N, Demiral U, et al. Relationship between serum GGT levels and liver fibrosis in chronic hepatitis B patients. Fırat Med J 2010;15:74-8.
18. Kim WR, Berg T, Asselah T et al. Evaluation of APRI and FIB-4 scoring systems for non-invasive assessment of hepatic fibrosis in chronic hepatitis B patients. J Hepatol 2016; 64:773-80.
19. Dai T, Jia S, Hao M et al. Transient elastography with serum hepatitis B surface antigen enhances liver fibrosis detection. Med Sci Monit 2016;22:2878-85.
20. Hanna RF, Kased N, Kwan SW, et al. Doublecontrast MRI for accurate staging of hepatocellular carcinoma in patients with cirrhosis. Am J Roentgenol 2008;190:47-57
21. Chen YP, Hou JL, Dai L, et al. Ultrasonic scores combined with blood indexes for screening and predicting compensated liver cirrhosis in chronic hepatitis B patients 2008;28:2157-60.
22. Liu H, Zhang H, Wan G, et al. Neutrophil-lymphocyte ratio: a novel predictor for short-term prognosis in acute-on-chronic hepatitis B liver failure. J Viral Hepat. 2014;21:499-507.
23. Celikbilek M, Dogan S, Gursoy S, et al. Noninvasive assessment of liver damage in chronic hepatitis B. World J Hepatol 2013;5:439-45.
24. Uluca U, Sen V, Gunes A, et al. Evaluation of neutrophil to lymphocyte ratio and mean platelet volume in inactive hepatitis B carriers. Mustafa Kemal University J Med 2015;6:8-13.
25. Ekiz F, Yuksel O, Kocak E, et al. Mean platelet volume as a fibrosis marker in patients with chronic hepatitis B. J Clin Lab Anal 2011;25:162-5.